What is LBRX's restricted cash?

LBRX (LBRX) reported restricted cash of $776K in Q1 2026.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

LBRX LBRX Restricted Cash

Restricted Cash at other companies

AlkermesALKS

$0—

MapLight Therapeutics, Inc. MPLT

$207K—

Alto NeuroscienceANRO

$500K0.0%

Acadia PharmaceuticalsACAD

$7.85M-10.5%

Septerna, Inc.SEPN

$905K0.0%

Rapport Therapeutics, Inc.RAPP

$105K0.0%

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$888.98M+163%

Enterprise value$571.77M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's restricted cash?: LBRX (LBRX) reported restricted cash of $776K in Q1 2026.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.